7 hours Brokers Issue Forecasts for Amicus Therapeutics, Inc.’s Q1 2025 Earnings (NASDAQ:FOLD) MarketBeat
Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) – Research analysts at Zacks Research boosted their Q1 2025 earnings estimates for Amicus Therapeutics in a research note issued to investors on Wednesday, October 2nd. Zacks Research analyst R. …
Earnings · Nasdaq 100 · Science